U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159555) titled 'Assessment of Neurofilaments Levels in Premature Newborns: Study of Their Early Development' on Aug. 28.
Brief Summary: This is a prospective observational study aiming to establish reference values of neurofilaments in late preterm newborns (34-37 weeks of gestation) and to evaluate their early postnatal evolution.
Neurofilaments are neuronal proteins released into the blood when nerve cells are damaged. They have emerged as promising biomarkers in neurodegenerative diseases, particularly in spinal muscular atrophy (SMA), where higher levels are associated with disease activity. However, very limited data exist on the normal dynam...